Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi

Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi

Prior Authorization Criteria - Evrysdi (Risdiplam) is a legal document that was released by the Mississippi Division of Medicaid - a government authority operating within Mississippi.

FAQ

Q: What is Evrysdi (Risdiplam)?
A: Evrysdi (Risdiplam) is a medication used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older.

Q: What is spinal muscular atrophy (SMA)?
A: Spinal muscular atrophy (SMA) is a rare genetic disease that affects the muscles and causes progressive muscle weakness and loss of movement.

Q: Who can take Evrysdi (Risdiplam)?
A: Evrysdi (Risdiplam) can be taken by adults and children 2 months of age and older who have been diagnosed with spinal muscular atrophy (SMA).

Q: What are the criteria for prior authorization of Evrysdi (Risdiplam) in Mississippi?
A: The specific criteria for prior authorization of Evrysdi (Risdiplam) may vary, and it is best to consult with your healthcare provider or insurance company for the most accurate and up-to-date information.

Q: How can I get prior authorization for Evrysdi (Risdiplam) in Mississippi?
A: To get prior authorization for Evrysdi (Risdiplam), you will need to contact your healthcare provider or insurance company and follow their specific procedures and requirements.

Q: Does Medicaid cover Evrysdi (Risdiplam) in Mississippi?
A: Medicaid coverage for Evrysdi (Risdiplam) in Mississippi may vary. It is recommended to check with your Medicaid provider for specific coverage details.

Q: Are there any alternative treatments for spinal muscular atrophy (SMA)?
A: Yes, there are other treatment options available for spinal muscular atrophy (SMA) such as Spinraza (nusinersen) and Zolgensma (onasemnogene abeparvovec). Your healthcare provider can determine the most suitable treatment for your specific condition.

Q: What are the common side effects of Evrysdi (Risdiplam)?
A: Common side effects of Evrysdi (Risdiplam) may include fever, diarrhea, rash, mouth ulcers, and upper respiratory tract infection. It is important to discuss any side effects with your healthcare provider.

Q: Can Evrysdi (Risdiplam) be taken during pregnancy?
A: The use of Evrysdi (Risdiplam) during pregnancy should be discussed with your healthcare provider. They can assess the potential risks and benefits and make the best decision for you and your baby.

Q: Is Evrysdi (Risdiplam) covered by private insurance in Mississippi?
A: Coverage of Evrysdi (Risdiplam) by private insurance in Mississippi may vary. It is recommended to check with your specific insurance provider for details regarding coverage and any prior authorization requirements.

ADVERTISEMENT

Form Details:

  • Released on April 6, 2021;
  • The latest edition currently provided by the Mississippi Division of Medicaid;
  • Ready to use and print;
  • Easy to customize;
  • Compatible with most PDF-viewing applications;
  • Fill out the form in our online filing application.

Download a printable version of the form by clicking the link below or browse more documents and templates provided by the Mississippi Division of Medicaid.

Download Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi

4.6 of 5 (15 votes)
  • Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi

    1

  • Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi, Page 2

    2

  • Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi, Page 3

    3

  • Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi, Page 4

    4

  • Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi, Page 1
  • Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi, Page 2
  • Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi, Page 3
  • Prior Authorization Criteria - Evrysdi (Risdiplam) - Mississippi, Page 4
Prev 1 2 3 4 Next
ADVERTISEMENT